Cathay Biotech Inc Cash Flow Quality Index
Cathay Biotech Inc cash flow quality index. Cathay Biotech Inc (688065) has a Cash Flow Quality Index of -0.47x as of September 2025. Operating cash flow of CN¥-66.22 Million is below net income of CN¥142.01 Million, suggesting accrual-heavy earnings not yet converted to cash. See Cathay Biotech Inc (688065) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Cathay Biotech Inc (2016–2025)
Cash flow quality index of Cathay Biotech Inc from 2016 to 2025. Historical Cash Flow Quality Index for Cathay Biotech Inc across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Cathay Biotech Inc (688065) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cathay Biotech Inc Cash Flow Quality Index by Year (2016–2025)
Cathay Biotech Inc cash flow quality index by year from 2016 to 2025. Year-by-year earnings quality comparison for Cathay Biotech Inc. For the full cash flow conversion analysis, see 688065 operating cash flow.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.71x | CN¥404.12 Million | CN¥565.72 Million | ▼ -58.7% |
| 2024 | 1.73x | CN¥820.93 Million | CN¥474.59 Million | ▲ +11.3% |
| 2023 | 1.55x | CN¥569.45 Million | CN¥366.52 Million | ▲ +18.4% |
| 2022 | 1.31x | CN¥803.67 Million | CN¥612.65 Million | ▲ +42.8% |
| 2021 | 0.92x | CN¥594.18 Million | CN¥646.68 Million | ▼ -18.4% |
| 2020 | 1.13x | CN¥514.96 Million | CN¥457.34 Million | ▲ +49.9% |
| 2019 | 0.75x | CN¥359.62 Million | CN¥478.88 Million | ▲ +3504.1% |
| 2018 | -0.02x | CN¥-10.29 Million | CN¥466.29 Million | ▼ -113.7% |
| 2017 | 0.16x | CN¥53.45 Million | CN¥332.73 Million | ▲ +118.2% |
| 2016 | -0.88x | CN¥-128.67 Million | CN¥145.47 Million | — |